Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: forgetme	1/18/2025 11:40:42 AM
	Read Replies (1) of 63304

I m not a newcomer. I was an immunomedics and immunogen investor until those those cos got taken over and made good money from those 2 trades. I came across a co which has similar potential as immu. The co has an masked epcam adc which has potential to beat immu valuation, The target was used by other cos be4 but failed because of toxicity. Cytomx adc is masked so it acts only on tumor environment. Currently , dose escalation is at level 6 and considered as therapeutic level. Ceo said MTD should be caused by the toxins and not the target from his recent presentation. ir.cytomx.com onclive.com different target but similar toxin topo dose was at 2.4mg Immunomedics pr director Dr. Chang worked for cytomx after taken over. He worked remotely in the east coast since cytomx is a located in the sf bayarea slide # 16 jpm health conference potential patient over 350000

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next